Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging Ltd reported quarterly revenue of $3.4 million, marking an increase from $3.0 million in the previous quarter, driven by stronger teleradiology utilization and improved margins. The company secured a distribution agreement with Imperial Imaging Technology, expanding its commercial access to the Nanox.ARC system in six Southeastern states, thereby enhancing its point-of-care imaging model. Moreover, management confirmed its 2026 revenue guidance of $35 million, showcasing strong commercial traction and a commitment to scaling its installed base while highlighting recent FDA 510(k) clearance for new cloud-enabled technology as a key advancement.

Bears say

Nano X Imaging Ltd. reported a decline in cash reserves, with total cash decreasing to $55.5 million from $83.2 million, indicating a significant operational cash burn of $30.4 million and notable use of at-the-market (ATM) financing. The company's GAAP gross loss remained high at $2.9 million, underlining ongoing substantial expenditures for system deployments and AI infrastructure, while the net loss remained stable at $13.7 million. Although operational execution continues, the extended timelines and increased investments for development, regulatory approval, and commercialization have contributed to a negative outlook on the stock's future performance.

Nano-X Imaging (NNOX) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Buy based on their latest research and market trends.

According to 2 analysts, Nano-X Imaging (NNOX) has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.